FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034209707> ?p ?o ?g. }

• W2034209707 endingPage "415" @default.
• W2034209707 startingPage "412" @default.
• W2034209707 abstract "The purine analog 2',3'-dideoxyinosine (ddI), which has anti-retroviral activity in vitro was administered for up to 42 weeks to 26 patients with acquired immunodeficiency syndrome (AIDS) or severe AIDS-related complex (ARC). Ten of these individuals were AZT-intolerant. Eight dose regimens were studied. The drug was orally bioavailable and penetrated into the cerebrospinal fluid (CSF). Comparatively little evidence of an effect against human immunodeficiency virus (HIV) was seen at the lowest four doses. However, patients in the four highest dose groups (ddI at 1.6 milligrams per kilogram intravenously and then greater than or equal to 3.2 milligrams per kilogram orally at least every 12 hours or higher) had increases in their circulating CD4+ T cells (P less than 0.0005), increased CD4/CD8 T cell ratios (P less than 0.01), and, where evaluable, more than an 80% decrease in serum HIV p24 antigen (P less than 0.05). The patients also had evidence of improved immunologic function, had reduced viremic symptomatology, and gained a mean of 1.6 kilogram with these comparatively infrequent dosing schedules (every 8 or 12 hours). The most notable adverse effects directly attributable to ddI administration at the doses used in this study included increases in serum uric acid (due to hypoxanthine release) and mild headaches and insomnia. These results suggest that serious short-term toxicity at therapeutic doses is not an inherent feature in the profile of agents with clinical anti-HIV activity. Further controlled studies to define the safety and efficacy of this agent may be worth considering." @default.
• W2034209707 created "2016-06-24" @default.
• W2034209707 creator A5017556487 @default.
• W2034209707 creator A5034448543 @default.
• W2034209707 creator A5041169651 @default.
• W2034209707 creator A5055830608 @default.
• W2034209707 creator A5060200906 @default.
• W2034209707 creator A5066414320 @default.
• W2034209707 creator A5072515095 @default.
• W2034209707 creator A5077622156 @default.
• W2034209707 creator A5079525770 @default.
• W2034209707 creator A5091721224 @default.
• W2034209707 date "1989-07-28" @default.
• W2034209707 modified "2023-09-27" @default.
• W2034209707 title "In Vivo Activity Against HIV and Favorable Toxicity Profile of 2′,3′-Dideoxyinosine" @default.
• W2034209707 cites W1576382588 @default.
• W2034209707 cites W1865355173 @default.
• W2034209707 cites W1982449739 @default.
• W2034209707 cites W1991249891 @default.
• W2034209707 cites W2011406016 @default.
• W2034209707 cites W2061566909 @default.
• W2034209707 cites W2082266431 @default.
• W2034209707 cites W2085459671 @default.
• W2034209707 cites W2086462809 @default.
• W2034209707 cites W2112362416 @default.
• W2034209707 cites W2133543557 @default.
• W2034209707 cites W2313181357 @default.
• W2034209707 cites W2333399282 @default.
• W2034209707 cites W2336515255 @default.
• W2034209707 cites W2340058544 @default.
• W2034209707 cites W4237110073 @default.
• W2034209707 cites W4253402896 @default.
• W2034209707 cites W4256221661 @default.
• W2034209707 doi "https://doi.org/10.1126/science.2502840" @default.
• W2034209707 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2502840" @default.
• W2034209707 hasPublicationYear "1989" @default.
• W2034209707 type Work @default.
• W2034209707 sameAs 2034209707 @default.
• W2034209707 citedByCount "405" @default.
• W2034209707 countsByYear W20342097072012 @default.
• W2034209707 countsByYear W20342097072013 @default.
• W2034209707 countsByYear W20342097072014 @default.
• W2034209707 countsByYear W20342097072015 @default.
• W2034209707 countsByYear W20342097072016 @default.
• W2034209707 countsByYear W20342097072018 @default.
• W2034209707 countsByYear W20342097072019 @default.
• W2034209707 countsByYear W20342097072020 @default.
• W2034209707 countsByYear W20342097072022 @default.
• W2034209707 crossrefType "journal-article" @default.
• W2034209707 hasAuthorship W2034209707A5017556487 @default.
• W2034209707 hasAuthorship W2034209707A5034448543 @default.
• W2034209707 hasAuthorship W2034209707A5041169651 @default.
• W2034209707 hasAuthorship W2034209707A5055830608 @default.
• W2034209707 hasAuthorship W2034209707A5060200906 @default.
• W2034209707 hasAuthorship W2034209707A5066414320 @default.
• W2034209707 hasAuthorship W2034209707A5072515095 @default.
• W2034209707 hasAuthorship W2034209707A5077622156 @default.
• W2034209707 hasAuthorship W2034209707A5079525770 @default.
• W2034209707 hasAuthorship W2034209707A5091721224 @default.
• W2034209707 hasBestOaLocation W20342097072 @default.
• W2034209707 hasConcept C126322002 @default.
• W2034209707 hasConcept C141071460 @default.
• W2034209707 hasConcept C150903083 @default.
• W2034209707 hasConcept C197934379 @default.
• W2034209707 hasConcept C203014093 @default.
• W2034209707 hasConcept C207001950 @default.
• W2034209707 hasConcept C2522874641 @default.
• W2034209707 hasConcept C2777288759 @default.
• W2034209707 hasConcept C2779127605 @default.
• W2034209707 hasConcept C2780727368 @default.
• W2034209707 hasConcept C2780966972 @default.
• W2034209707 hasConcept C29730261 @default.
• W2034209707 hasConcept C71924100 @default.
• W2034209707 hasConcept C86803240 @default.
• W2034209707 hasConcept C98274493 @default.
• W2034209707 hasConceptScore W2034209707C126322002 @default.
• W2034209707 hasConceptScore W2034209707C141071460 @default.
• W2034209707 hasConceptScore W2034209707C150903083 @default.
• W2034209707 hasConceptScore W2034209707C197934379 @default.
• W2034209707 hasConceptScore W2034209707C203014093 @default.
• W2034209707 hasConceptScore W2034209707C207001950 @default.
• W2034209707 hasConceptScore W2034209707C2522874641 @default.
• W2034209707 hasConceptScore W2034209707C2777288759 @default.
• W2034209707 hasConceptScore W2034209707C2779127605 @default.
• W2034209707 hasConceptScore W2034209707C2780727368 @default.
• W2034209707 hasConceptScore W2034209707C2780966972 @default.
• W2034209707 hasConceptScore W2034209707C29730261 @default.
• W2034209707 hasConceptScore W2034209707C71924100 @default.
• W2034209707 hasConceptScore W2034209707C86803240 @default.
• W2034209707 hasConceptScore W2034209707C98274493 @default.
• W2034209707 hasIssue "4916" @default.
• W2034209707 hasLocation W20342097071 @default.
• W2034209707 hasLocation W20342097072 @default.
• W2034209707 hasLocation W20342097073 @default.
• W2034209707 hasOpenAccess W2034209707 @default.
• W2034209707 hasPrimaryLocation W20342097071 @default.
• W2034209707 hasRelatedWork W2005131769 @default.
• W2034209707 hasRelatedWork W2009786324 @default.

• next